The safety of anti PD-1 therapeutics for the treatment of melanoma.

about

DNA repair and systemic lupus erythematosus.Endocrine toxicity of immune checkpoint inhibitors: essential crosstalk between endocrinologists and oncologists.Safety and efficacy profile of pembrolizumab in solid cancer: pooled reanalysis based on randomized controlled trials.

P2860

Q39379165-753B4597-C2F5-493B-BD31-FD7374CD9077 Q39441719-2BD4C333-2E3C-4CCC-B0A6-D190A285A3D5 Q42370605-07A5A253-B477-4F01-A56F-A22F2474D413

P2860

The safety of anti PD-1 therapeutics for the treatment of melanoma.

Item

http://www.wikidata.org/entity/Q38979801

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

The safety of anti PD-1 therapeutics for the treatment of melanoma.

@en

type

Item

label

The safety of anti PD-1 therapeutics for the treatment of melanoma.

@en

prefLabel

The safety of anti PD-1 therapeutics for the treatment of melanoma.

@en

P1476

The safety of anti PD-1 therapeutics for the treatment of melanoma.

@en

P2093

Egle Ramelyte

http://www.w3.org/2001/XMLSchema#string

Reinhard Dummer

http://www.w3.org/2001/XMLSchema#string

P2860

CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

The PD-1 pathway in tolerance and autoimmunity

Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.

Improved overall survival in melanoma with combined dabrafenib and trametinib.

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

The blockade of immune checkpoints in cancer immunotherapy

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Immune checkpoint blockade: a common denominator approach to cancer therapy

PD-1 and its ligands in tolerance and immunity

P304

41-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14740338.2016.1248402

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sabrina A Schindler

P577

2016-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27737598

http://www.w3.org/2001/XMLSchema#string

The safety of anti PD-1 therapeutics for the treatment of melanoma.

about

P2860

P2860

The safety of anti PD-1 therapeutics for the treatment of melanoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698